Diagnostic and prognostic potential of circulating long non-coding RNAs in non small cell lung cancer

W Peng, J Wang, B Shan, Z Peng, Y Dong… - Cellular Physiology and …, 2018 - karger.com
Lung cancer is the leading cause of cancer-related mortality worldwide. Approximately 80%
of lung cancer cases are non–small cell lung carcinoma (NSCLC). However current …

Ang-(1-7)/MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma

AZ El-Hashim, MA Khajah, RS Babyson, WM Renno… - PLoS …, 2019 - journals.plos.org
The angiotensin-(1–7)[Ang-(1–7)]/MAS1 receptor signaling axis is a key endogenous anti-
inflammatory signaling pathway. However, the mechanisms by which its mediates the anti …

Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation

S Zhou, H Wang, W Jiang, Q Yu - OncoTargets and therapy, 2019 - Taylor & Francis
Objective This study analyzed the relationship between the clinicopathological features and
epidermal growth factor receptor (EGFR) mutation status of squamous cell lung cancer …

[HTML][HTML] Mutation profile in liquid biopsy tested by next generation sequencing in Mexican patients with non-small cell lung carcinoma and its impact on survival

JF Martínez-Herrera, GS Domínguez… - Journal of Thoracic …, 2024 - ncbi.nlm.nih.gov
Background Lung cancer represents a significant global health concern, often diagnosed in
its advanced stages. The advent of massive DNA sequencing has revolutionized the …

Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma

C Zhang, H Yang, B Lang, X Yu, P Xiao… - Cancer management …, 2018 - Taylor & Francis
Background Primary adenosquamous carcinoma (ASC) of the lung is a rare and aggressive
disease. The accurate diagnosis of ASC based on small biopsies is challenging because of …

CD117 expression is correlated with poor survival of patients and progression of lung carcinoma: a meta-analysis with a panel of 2645 patients

Y Guo, L Liang, S Ren, M Wu, D Shi, W Mo… - Polish Journal of …, 2019 - termedia.pl
The aim of this research was to investigate the clinical role and prognostic value of CD117
expression assessed immunohistochemically in lung carcinoma through a comprehensive …

[PDF][PDF] 1 例EGFR 敏感突变局部晚期肺鳞癌病例报告及文献复习

詹志翔, 冯海林, 廖凌峰 - 临床与病理杂志, 2020 - cdn.amegroups.cn
报告1 例信阳市中心医院经病理确诊, EGFR 检测敏感突变的局部晚期肺鳞癌,
该患者为一老年男性, 不能耐受同步放化疗后序贯接受表皮生长因子受体-酪氨酸激酶抑制剂 …

[PDF][PDF] Tobacco control and lung cancer

M Fukuda, H Mukae, K Ashizawa - Oncology Research and …, 2017 - siriusstore.com
Tobacco smoking is a major risk factor for early death, and smoking cessation is an
important public health issue as it has health benefits. Passive smoking is a significant …

[PDF][PDF] Diagnostic du cancer du poumon

S Arcioni - 2018 - sonar.ch
En Suisse, le cancer du poumon est le 2ème cancer le plus fréquent chez l'homme (après
celui de la prostate) et le troisième chez la femme (après celui du sein et le colo-rectal)[1]. Il …

[引用][C] Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib.

M Yamasaki, K Funaishi, W Daido… - Archivos de …, 2019 - europepmc.org
Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …